European Wax Center 株価情報 (NASDAQ: EWCZ)

European Wax Center (NASDAQ:EWCZ) 株価情報

European Wax Center

European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.

European Wax Center, Inc. - Class A Common Stock

European Wax Center Inc

Mortgage rates are coming down to the lowest levels since last December, but demand for home loans has stalled. Here's a look at what the experts are forecasting<a href="https://www.benzinga.com/real-estate/25/02/43731246/a-recipe-for-market-instability-fed-chief-powell-predicts-mortgages-wont-be-available-in-some-regions-but-it-has-nothing-to-do-rates"> for the year ahead.&nbsp;</a>
What To Know: The average interest rate for 30-year fixed-rate mortgages continued to decline to 6.88% in the week ended Feb. 21, down from 6.93% in the previous week. According to the Mortgage Bankers Association, last week's <a href="https://www.mba.org/news-and-research/newsroom/news/2025/02/26/mortgage-applications-decrease-in-latest-mba-weekly-survey">average rate</a> marks a new low since December 2024 and compares to 7.03% from the same period last year.&nbsp;
Read Next:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43949800/tesla-competes-against-chinese-rivals-with-one-hand-tied-behind-its-back-analyst"> Tesla Competes Against Chinese Rivals &#8216;With One Hand Tied Behind Its Back&#8217;: Analyst</a>
"Treasury yields moved lower on softer consumer spending data as consumers are feeling somewhat less upbeat about the economy and job market. This pushed mortgage rates lower, with the 30-year fixed rate decreasing to 6.88 percent, the lowest rate since mid-December," said Joel Kan, MBA's Vice President and Deputy Chief Economist.&nbsp;
Though mortgage rates are slowly coming down, demand for home loans remains weak. MBA data show applications to refinance a home loan fell 4% for the week and <a href="https://www.benzinga.com/25/02/43873151/mortgage-rates">existing home sales</a> in the U.S. sank by 4.9% in January, the sharpest decline in seven months. 
Analysts at JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) see the housing market <a href="https://www.jpmorgan.com/insights/global-research/real-estate/us-housing-market-outlook">to remain </a>"largely stuck" through 2025 as interest rates and home prices both remain high. 
"The situation is not going to change until we get mortgage rates back down toward 5%, or even lower," said John Sim, head of Securitized Products Research at J.P. Morgan.
"And we aren't forecasting mortgage rates to breach 6% in 2025 — they should ease only slightly to 6.7% by the year end," Sim added.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">Financial Crime Weekly: $1.4 Billion Ethereum Stolen In Largest Crypto Hack Ever, SEC Creates Cyber And Emerging Technologies Unit</a></li>
</ul>
Image: Shutterstock

News

Bonds

Econ #s

Economics

Markets

Real Estate

Mortgage Rates Drop To Lowest Levels Since December, But Housing Market Remains 'Largely Stuck'

Wedbush analyst Michael Pachter reiterates Playtika Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTK#NASDAQ">PLTK</a>) with a Outperform and maintains $11.5 price target.

Price Target

Reiteration

Analyst Ratings

PLTK

Wedbush Reiterates Outperform on Playtika Holding, Maintains $11.5 Price Target

JP Morgan analyst Matthew Boss maintains Amer Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AS#NYSE">AS</a>) with a Overweight and raises the price target from $33 to $34.

JP Morgan Maintains Overweight on Amer Sports, Raises Price Target to $34

Morgan Stanley analyst Matthew Cost maintains Webtoon Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBTN#NASDAQ">WBTN</a>) with a Equal-Weight and lowers the price target from $16 to $13.

WBTN

Morgan Stanley Maintains Equal-Weight on Webtoon Entertainment, Lowers Price Target to $13

The past decade has been the hottest on record. 2024 just clocked in at 1.55°C above pre-industrial levels. With heat waves, wildfires and extreme weather wreaking havoc, JPMorgan <a href="https://www.benzinga.com/topic/climate-change">says climate adaptation</a> is no longer optional—it's an investment necessity.
In a new report, the firm highlights 157 stocks poised to benefit from climate adaptation, spanning renewable energy, water security, infrastructure, and climate risk analytics. Of those, 75 stocks carry an Overweight rating—a strong signal to investors looking for companies positioned to thrive in an increasingly volatile climate.
We&#8217;re highlighting the ones that JPMorgan is &#8216;Overweight&#8217; on from the North American region. These are the top stocks U.S. investors could consider while re-shuffling or adding to their ESG investing portfolios.
<h2 class="wp-block-heading">Industrials: Strengthening Supply Chains For A Warming World</h2>
<ul>
<li>Resideo Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REZI#NYSE">REZI</a>) – Offers smart home climate controls optimizing energy and water use amid rising utility costs.</li>
<li>AGCO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) – Precision agriculture leader helping farmers combat erratic weather patterns and declining crop yields.</li>
<li>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) – Battery storage solutions critical for stabilizing power grids as heat waves push electricity demand to record highs.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/general/travel/25/02/43814828/life-threatening-cold-air-snow-brings-travel-delays-higher-heating-costs">&#8216;Life-Threatening&#8217; Cold Air, Snow Brings Travel Delays, Higher Heating Costs</a>
<h2 class="wp-block-heading">Tech: The Brains Behind Climate Adaptation</h2>
<ul>
<li>Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) &amp; Solaredge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) – Smart solar inverters making decentralized energy grids more resilient.</li>
<li>Verisk Analytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>) – A go-to player in climate risk modeling, helping insurers and businesses mitigate financial exposure to extreme weather.</li>
</ul>
<h2 class="wp-block-heading">Beyond Renewables: The Under-The-Radar Climate Winners</h2>
<ul>
<li>Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) – Hydropower and energy storage investments ensuring grid reliability in an unpredictable climate.</li>
<li>Americold Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) – Cold-storage solutions safeguarding food supply chains from heat-induced spoilage.</li>
</ul>
With COP30 expected to drive global climate policy, JPMorgan sees these companies gaining as governments and corporations ramp up adaptation investments. 
For investors, the takeaway is clear: climate change isn't just a threat—it's an opportunity.
Is your portfolio ready for the shift?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43900360/bill-gates-has-a-warning-for-the-next-generation-says-be-very-afraid-of-these-4-issues">Bill Gates Has A Warning For The Next Generation, Says Be &#8216;Very Afraid&#8217; Of These 4 Issues</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Trading Ideas

AGCO

COLD

ENPH

FLNC

REZI

SEDG

VRSK

Adapt Or Get Left Behind: JPMorgan's Top Stocks For A Hotter World

Morgan Stanley analyst Simon Flannery maintains Globalstar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSAT#NASDAQ">GSAT</a>) with a Equal-Weight and raises the price target from $14.85 to $25.

GSAT

Morgan Stanley Maintains Equal-Weight on Globalstar, Raises Price Target to $25

Wedbush analyst Scott Devitt maintains Maplebear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) with a Neutral and lowers the price target from $48 to $46.

CART

Wedbush Maintains Neutral on Maplebear, Lowers Price Target to $46

Wedbush analyst Seth Basham reiterates Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) with a Outperform and maintains $440 price target.

Wedbush Reiterates Outperform on Home Depot, Maintains $440 Price Target

On Wednesday, Steven Madden (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>)&nbsp;reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43968741/steve-madden-announces-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener">fourth-quarter&nbsp;2024 financial results</a>.
It clocked a fourth-quarter adjusted EPS of 55 cents,&nbsp;beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">Wall Street View of 53 cents</a>. Quarterly revenues of&nbsp;$582.32 million&nbsp;increased&nbsp;12.0%&nbsp;year over year, surpassing the analyst consensus of&nbsp;$548.50 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43952697/micron-expands-ai-chip-capabilities-with-faster-more-efficient-dram-for-next-gen-devices" rel="noreferrer noopener">Micron Expands AI Chip Capabilities With Faster, More Efficient DRAM for Next-Gen Devices</a>
Revenue from direct-to-consumer was&nbsp;$176.0&nbsp;million, an&nbsp;8.4%&nbsp;increase year over year. Revenue from the wholesale business was&nbsp;$402.9&nbsp;million, a&nbsp;13.6%&nbsp;increase year over year.
Gross profit as a percentage of revenue was&nbsp;40.4%&nbsp;compared to&nbsp;41.3%&nbsp;in the same period of 2023. Adjusted operating expenses as a percentage of revenue were&nbsp;31.4%&nbsp;compared to&nbsp;31.5%&nbsp;in the same period of 2023.
The footwear company ended the quarter with 291&nbsp;company-operated brick-and-mortar retail stores, five e-commerce websites, and 42 company-operated concessions in international markets.
As of December 31, cash and equivalents and short-term investments totaled&nbsp;$203.4&nbsp;million, and inventory totaled&nbsp;$257.6&nbsp;million.
Chair and CEO Edward Rosenfeld remains cautious on the near-term outlook, as it faced meaningful headwinds in 2025, most notably the impact of new tariffs on goods imported into the U.S.
However, he expressed optimism over the pending acquisition of Kurt Geiger, likely to close in the second quarter of 2025, whose differentiated and elevated positioning, expanding in international markets, accessories categories, and direct-to-consumer channels make it a highly attractive and complementary addition to the company&#8217;s portfolio.
FY25 Outlook: Steven Madden expects revenue growth of 17%-19%, implying revenue of $2.67 billion-$2.72 billion against the consensus of $2.33 billion.
It expects EPS of $2.30-$2.40. The consensus&nbsp;estimate for <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">EPS is $2.58</a>.
Price Action: SHOO stock traded lower by 5.22% at $35.91 at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/02/43953046/stmicroelectronics-faces-leadership-shakeup-italy-seeks-new-ceo-amid-semiconductor-struggles" target="_blank" rel="noreferrer noopener">STMicroelectronics Faces Leadership Shakeup, Italy Seeks New CEO Amid Semiconductor Struggles</a></li>
</ul>
Photo by DCStockPhotography via Shutterstock

Earnings

Guidance

Movers

SHOO

Steven Madden Q4 Performance Beats Expectations But CEO Cautions About 2025 Profit Impact From Tariff Headwinds

Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>) with a Overweight and lowers the price target from $100 to $85.

Morgan Stanley Maintains Overweight on Sempra, Lowers Price Target to $85

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/02/2025-02-26_09h15_32-1.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">King Nvidia Earnings Ahead</h4>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-nvidia-earnings-budget-plan-nvda-mc-02262025">click here</a> for an enlarged chart of NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Note the following:
<ul>
<li>This article is about the big picture, not about an individual stock.&nbsp; The chart of NVDA stock is being used to illustrate the point.</li>
<li>The chart shows NVDA stock is below the resistance zone.</li>
<li>RSI on the chart shows NVDA stock is neither overbought nor oversold.</li>
<li>The chart shows a nicely profitable recently completed trade around position on NVDA based on Arora signals.&nbsp; The NVDA trade around position was separate and distinct from the core NVDA position that is being held for $12.55.</li>
<li>Nvidia will report earnings today after the close.&nbsp; Nvidia earnings have the potential to move the stock market in either direction.&nbsp; At The Arora Report, we will be carefully listening for future demand.</li>
<li>The momo crowd is ignoring the potential risk to the downside and buying stocks ahead of Nvidia earnings.</li>
<li>The House has passed a plan for the budget.  Here are the key points:
<ul>
<li>The plan calls for $1.5T &#8211; $2T in spending cuts over a decade.</li>
<li>The plan calls for $4T &#8211; $4.5T in tax cuts.</li>
<li>The plan calls for large cuts in Medicaid.&nbsp; Medicaid is a safety net health insurance program for low income people.</li>
<li>The stage is set for a showdown with the Senate.&nbsp; Senate Republicans want larger tax cuts.</li>
</ul>
</li>
<li>The passage of the bill is generating excitement among investors, and they are aggressively buying stocks.&nbsp; As heartless as it sounds, irrespective of your opinion, in the early trade, there is aggressive buying in the stock market for two reasons:
<ul>
<li>Higher income people will benefit more from tax cuts.&nbsp; It is the higher income people who invest in stocks.</li>
<li>Lower income people who are on Medicaid will be adversely affected, but they are much less likely to invest in stocks.</li>
</ul>
</li>
<li>Adding to the buying is news from China.&nbsp; Please see the section below.</li>
<li>Copper prices are moving higher on Trump's plan for tariffs on copper.</li>
</ul>
<h4 class="wp-block-heading">China</h4>
China is injecting $55B into its largest banks.&nbsp; The purpose is to increase lending and spur the economy.&nbsp; Foreign money is flowing into Chinese stocks.
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and NVDA.
In the early trade, money flows are negative in Apple Inc (AAPL).
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is seeing selling pressure.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.&nbsp; The proprietary protection band from The Arora Report is very popular.&nbsp; The protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Equities

Market Summary

NVDA

TSLA

Stock Buying Ahead Of Nvidia Earnings On Potential Tax Cuts And Large Medicaid Cuts

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update in connection with the filing of its Annual Report on Form 10-K for the year ended December 31, 2024.
Shuttle Pharma's recent highlights include the following:
<ul>
<li>Accelerated patient enrollment of the Company's key Phase 2 clinical trial of Ropidoxuridine for treatment of patients with glioblastoma with 40% enrollment in the initial randomized portion. As of today, a total of 16 of the initial 40 patients have been enrolled, with 8 of the 16 patients having completed all seven cycles.</li>
<li>The Phase 2 trial is being conducted at nationally recognized cancer centers, including Georgetown University Medical Center, Allegheny Health Network (AHN) Cancer Institute, UNC Medical Center, the UVA Cancer Center, John Theurer Cancer Center at Hackensack University Medical Center, and Miami Cancer Institute, part of Baptist Health South Florida.</li>
<li>Continued advancement of the Company's Diagnostics subsidiary through the entry of a sponsored research agreement with the University of California, San Francisco (UCSF) to advance pre-clinical development of a ligand to the prostate-specific membrane antigen (PSMA) as a potential diagnostic and therapeutic, or theranostic, molecule. Theranostic molecules are suitable for diagnosis and therapy of cancers.</li>
<li>Launched new corporate website highlighting Shuttle Pharma's dual approach to Cancer Therapeutics and Diagnostics. Visit <a href="https://shuttlepharma.com/">https://shuttlepharma.com/</a> to learn more about how Shuttle Pharma is developing novel therapies designed to increase cancer cure rates, prolong patient survival, and improve quality of life.</li>
<li>Management has made significant investments into the business, including the Company's Chief Executive Officer, Dr. Anatoly Dritschilo, providing $237,500 along with other investors in a recent financing transaction.</li>
</ul>

SHPH

Shuttle Pharmaceuticals Provides Corporate Update On Phase 2 Glioblastoma Trial Enrollment, Diagnostics Advancements With UCSF, Launch Of New Corporate Website, And $237,500 Investment By CEO Dr. Anatoly Dritschilo And Other Investors In Recent Financing

Morgan Stanley analyst Brian Nowak maintains Maplebear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) with a Equal-Weight and raises the price target from $44 to $45.

Morgan Stanley Maintains Equal-Weight on Maplebear, Raises Price Target to $45

Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

WIIM

LUMN

Lumen Technologies shares are trading higher after Citigroup Rollins the stock from Neutral to Buy.

Morgan Stanley analyst James Faucette maintains Flywire (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>) with a Equal-Weight and lowers the price target from $21 to $15.

FLYW

Morgan Stanley Maintains Equal-Weight on Flywire, Lowers Price Target to $15

Wedbush analyst Robert Driscoll reiterates Day One Biopharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) with a Outperform and maintains $32 price target.

DAWN

Wedbush Reiterates Outperform on Day One Biopharmaceutical, Maintains $32 Price Target

UBS analyst Roger Boyd maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and raises the price target from $396 to $450.

CRWD

UBS Maintains Buy on CrowdStrike Holdings, Raises Price Target to $450

PTC's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NYSE">PTC</a>) short percent of float has fallen 26.77% since its last report. The company recently reported that it has 1.76 million shares sold short, which is 2.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>PTC Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740584747_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PTC has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing PTC's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, PTC's peer group average for short interest as a percentage of float is 3.03%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is the Market Bullish or Bearish on PTC?

ZoomInfo Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NYSE">ZI</a>) short percent of float has fallen 15.7% since its last report. The company recently reported that it has 11.74 million shares sold short, which is 3.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>ZoomInfo Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740584742_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for ZoomInfo Technologies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing ZoomInfo Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, ZoomInfo Technologies's peer group average for short interest as a percentage of float is 7.06%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Comments

European Wax Center

ニュース

パートナーシップ

ベンジンガ・グローバル